TRUDY JANICE PHILIPS

Ms. TRUDY JANICE PHILIPS

Mayo Clinic, Rochester, Indiana, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
FTFrancis Kwame Morgan Tetteh
Francis Kwame Morgan Tetteh
RFRaymond Fatchu
Raymond Fatchu
KAKingsley Ackah
Kingsley Ackah
TPTRUDY JANICE PHILIPS
TRUDY JANICE PHILIPS
HSHemant Deepak Shewade
Hemant Deepak Shewade
EAEmmanuel Parbie Abbeyquaye
Emmanuel Parbie Abbeyquaye
In this study, we described the bacterial profile, antibiotic resistance pattern, and laboratory result turnaround time (TAT) in neonates with suspected sepsis from a tertiary-level, military hospital in Accra, Ghana (2017–2020). This was a cross-sectional study using secondary data from electronic medical records. Of 471 neonates clinically diagnosed with suspected sepsis in whom blood samples were collected, the median TAT from culture request to report was three days for neonates who were culture-positive and five days for neonates who were culture-negative. There were 241 (51%) neonates discharged before the receipt of culture reports, and of them, 37 (15%) were culture-positive. Of 471 neonates, twenty-nine percent (n = 139) were bacteriologically confirmed, of whom 61% (n = 85) had late-onset sepsis. Gram-positive bacterial infection (89%, n = 124) was the most common cause of culture-positive neonatal sepsis. The most frequent Gram-positive pathogen was coagulase-negative Staphylococcus (55%, n = 68) followed by Staphylococcus aureus (36%, n = 45), of which one in two were multidrug resistant. The reasons for large numbers being discharged before the receipt of culture reports need to be further explored. There is a need for improved infection prevention and control, along with ongoing local antimicrobial resistance surveillance and antibiotic stewardship to guide future empirical treatment.

1 January 2024 in BioMed Research International
Verified
Journal Article
Open access
EAEunice Etornam Ampem-Danso
Eunice Etornam Ampem-Danso
EDEunice Dotse
Eunice Dotse
AAAbigail Aning
Abigail Aning
TPTRUDY JANICE PHILIPS
TRUDY JANICE PHILIPS
SHSherif Hamidu
Sherif Hamidu
JAJanet Ampofo
Janet Ampofo
Introduction:Vernonia amygdalina Delile (VAD), also known as bitter leaf, is widely utilized in traditional medicine for the treatment of various ailments, including cancer. The presence of bioactive compounds in VAD is believed to be responsible for its characteristic bitterness. In Ghana, it is a common practice to mitigate the bitterness of VAD by combining it with Citrus aurantifolia (Christm.) Swingle (lime) juice extracts, although this method lacks scientific evidence and documentation. Therefore, the antioxidant and anticancer activities of VAD and lime juice extracts (V5) and their combined effects were evaluated in vitro.Method: The antioxidant activity and cytotoxic effects of VAD extracts were determined against Jurkat, MCF‐7, HepG2, and PNT2 cells using the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) assay to quantify antioxidant activity and the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay to assess cytotoxicity. The statistical analysis of the data was conducted using Microsoft Excel and GraphPad Prism 8.0. Linear regression was employed to determine the correlation between the concentration and the percentage of antioxidant activity, while p values were calculated using Student’s t‐test.Results: The laboratory analysis focused on the extracts V1, V2, V3, V4, and V5. Briefly, V1 and V2 contained equal amounts of saponins and terpenoids. Among these, V2 exhibited the highest free radical scavenging activity, as indicated by an EC50 value of 2.14 ± 0.06 mg/mL. V2 also demonstrated cytotoxicity against the MCF‐7, HepG2, Jurkat, and PNT2 cell lines. On the other hand, V3 and V4 did not show any cytotoxic effects across all tested cell lines. In contrast, V5 was toxic to HepG2 and MCF‐7 cells but had no cytotoxic effect on Jurkat cell lines. V2 exhibited dose‐dependent cytotoxicity (0–1000 μg/mL), with the strongest inhibition observed against Jurkat cells (IC50 value = 96.341 μg/mL) and a selective index of 3.567. The difference in activity between the extracts from different parts of the plant and the extract combined with lime juice was significant (p < 0.05), indicating a synergistic effect of the phytochemicals in both VAD and lime juice.Conclusion: V2 and V5 demonstrated a remarkable antioxidant property, and they are effective in inhibiting cancer cell lines, respectively.